A 50-week, placebo-controlled trial shows that combining infliximab and methotrexate provides no extra benefit in treating Crohn’s disease.

References and Resources
Feagan B. A randomized trial of methotrexate in combination with infliximab for the treatment of Crohn’s disease. Digestive Disease Week; 2008: Abstract 682c.